writteninfo.com

5 weeks ago, Wall Street was mostly convinced that the economy was about to turn a corner. At the time, traders were piling into the stock market, chasing big gains and selling everything risk-averse. Mortgage bonds were in very low demand and the supply glut pushed rates north of 6 percent. Since then, [...]

So that brings us to today’s Federal Open Market Committee meeting. Looking at the chart at top, markets are 99.3% certain that the Federal Reserve won’t raise the Fed Funds Rate from its current range of “near-zero”. Investors have come to this conclusion because the Fed has repeatedly said it will keep the Fed [...]

This past weekend, while I was enjoying the beauties of nature — and the company of my family — in Idaho, the leaders of the G8 were having a meeting in Italy. Members of the G8 spent most of the time patting themselves on the back, telling each other that they had done a marvelous [...]

It’s been nearly five years since Merck pulled Vioxx off the market, but it will be a while longer before the legal system is through with the case.
The Supreme Court said yesterday that it would hear Merck’s appeal in a lawsuit filed by shareholders who argue that the company misled them by downplaying data that [...]

We’ve been programmed to want things fast and snappy. So it’s no surprise that financial types and investors and others are clinging to the idea that if we hit a bottom, we should be prepped for a quick recovery from the recession. Indeed, this idea is often expressed as a V-shaped recession. Look at the [...]

Dendreon’s gyrations continue: The biotech company’s shares surged this morning after a sudden plunge yesterday as Dendreon was to about to announce details of its latest Provenge study.
The share price more than doubled to $25.42 in morning trading. This comes after the shares’ roller-coaster ride yesterday, in which they hit a 52-week high of $25, [...]

Not too long ago, I jumped on the P2P lending bandwagon, giving Lending Club a try. There are a number of P2P lending sites, allowing for variations that include microloans to the poverty-stricken and student loan P2P lending that focuses on helping students with college costs. And now, if Prosper has its way, it will [...]

The FDA was a bit quick on the trigger in making public some documents about AstraZeneca’s Seroquel this morning.
The agency posted briefing documents on its Web site for an advisory committee meeting coming up on Wednesday to discuss AstraZeneca’s application for approval of an extended-release version of Seroquel for generalized anxiety disorder and major depression. [...]

The healthcare marketplace is changing dramatically – at Valida Primary Care we believe these changes create significant and exciting opportunities for primary care practices.
We are a group of healthcare executives and investors with years of experience growing and improving provider…